Pharmaceutical Sales Training (Rep shaking doctor hand)

Lessons from Training Pharmaceutical Sales Teams: Insights from the Field

When the pandemic forced teams to shift away from in-person meetings, pharmaceutical sales training leaders had to rethink how they prepared reps for conversations with healthcare professionals. Virtual and hybrid learning models, once considered secondary to live training, quickly became essential. Now, even as in-person meetings return, companies find that a mix of formats works…

Read More

How AI and Innovation Are Reshaping Pharma Sales Training in 2025

AI was novel in pharma training in early 2024. In 2025, it’s everywhere. At LTEN’s last 24 webinars, half had “AI” in the title. However, not all AI solutions are created equal. Many are little more than chatbots or “thin wrappers”—essentially fancy interfaces for ChatGPT or Claude. While these tools have their place, they don’t…

Read More
Sales Struggle: 5 Common Sales Team Challenges and how to fix them

5 Common Sales Team Challenges and How to Fix Them

In ‘The Sales Struggle: 5 Common Sales Team Challenges and How to Fix Them,’ we examine the key obstacles hindering sales teams and provide actionable solutions to enhance performance and morale. Learn how to address issues like poor communication, lack of motivation, and more to ensure your sales team operates at its peak. Discover essential strategies to drive success and cohesion within your team.

Read More

How to Boost Pharma Sales AI Training with AI Insights

Pharmaceutical sales opportunities are notoriously high stakes. With current trends suggesting that healthcare practitioners (HCPs) will continue to cut back on the amount of time devoted to one-on-one meetings with sales reps, every nuance of each interaction carries significant weight. In response, forward-thinking corporate decision-makers nationwide are turning to AI-based sales training for pharmaceutical reps,…

Read More

Boosting AI Sales Growth in Life Sciences: Expert Insights

Explore the transformative impact of AI on sales growth in the pharmaceutical industry. Learn how leading companies like Viatris, Roche, and Harvard Business School are leveraging AI to enhance sales strategies and drive market expansion. Gain insights on boosting sales performance and staying competitive with AI-driven innovations.

Read More

Mainstream Adoption of AI in Pharma Training

Generative AI Has Crossed the Chasm for Life Sciences Educators. With fully 35% of respondents believing that we are in the Early Majority stage of adoption, it’s clear that many teams – such as Sanofi’s North American Learning Experience Team – are treating this as a business imperative to remain competitive.

Read More

How AI Can Improve Your Pharmaceutical Sales Rep Certification Program

Executive Summary The US pharmaceutical sales industry made $53.6 billion in revenue in 2023—but despite that high number, only 41% of Americans have a degree of trust in pharmaceutical companies. This presents a significant opportunity for sales organizations to grow by enhancing their sales reps’ training programs. This article explores how AI pharmaceutical certifications can…

Read More
woman practicing with virtual coach

Statistical Evidence of the Value of Practice for Pharma Sales

Ah, the President’s Club. Perhaps the most prestigious recognition in sales, awarded to top achievers who have met and often exceeded ambitious sales goals. The award often comes with cash prizes or exclusive, all-expense paid vacations to high-end locations. The more indelible benefit is being able to add “President’s Club winner” to one’s resume.  What…

Read More
Sales Coaching practice

How to Measure Sales Coaching Effectiveness in Pharma

Executive Summary The pharmaceutical industry is undergoing significant changes, driving the need for innovative sales coaching methods. AI sales coaching has emerged as a crucial tool, providing highly individualized training that helps sales reps become more effective amidst market volatility. According to PwC’s 2024 outlook, pharma deal activity is down 25%, with deal values plummeting…

Read More